GlobeNewswire by notified

Share Buyback Programme: Week ending 11 October 2019

Share

EUROCASTLE INVESTMENT LIMITED

                                                                                                            FOR IMMEDIATE RELEASE
Contact:
International Administration Group (Guernsey) Limited
Company Administrator
Attn:  Mark Woodall
Tel:  +44 1481 723450                                                              

Share Buyback Programme: Transactions in week ending 11 October 2019



Guernsey, 14 October 2019 – Eurocastle Investment Limited (“Eurocastle” or the “Company”) today announces that between 7 October 2019 and 11 October 2019, under its fifth non-discretionary share buyback programme with Liberum Capital Limited (acting as the Company's broker) announced on 9 August 2019 and commenced on 16 September 2019 (the “Fifth Buyback Programme”), it bought back 11,584 of its ordinary shares at an average price of €7.32 per ordinary share. The purchased shares will all be held as treasury shares.

The purpose of the share buyback programme is to reduce the share capital of the Company and the programme is executed in compliance with the provisions of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016, collectively referred to as the Safe Harbour rules.

The following transactions have been made under the buyback programme:

Accumulated, most recent announcement Platform code Volume Volume Weighted Average Price Gross Value (€)
07/10/2019 BATE 279 7.30 2,037
  XLON 1,856 7.29 13,526
  CHIX 155 7.30 1,132
  TRQX 91 7.30 664
  Total 2,381 7.29 17,358
08/10/2019 BATE 283 7.30 2,066
  XLON 2,060 7.32 15,072
  CHIX 158 7.30 1,153
  TRQX 92 7.30 672
  Total 2,593 7.31 18,963
09/10/2019 BATE 283 7.34 2,077
  XLON 2,019 7.35 14,833
  CHIX 158 7.34 1,160
  TRQX 88 7.34 646
  Total 2,548 7.35 18,716
10/10/2019 BATE 278 7.32 2,035
  XLON 2,084 7.32 15,253
  CHIX 254 7.32 1,859
  TRQX 91 7.32 666
  Total 2,707 7.32 19,814
11/10/2019 BATE 236 7.34 1,732
  XLON 745 7.28 5,427
  CHIX 257 7.34 1,886
  TRQX 117 7.34 859
  Total 1,355 7.31 9,905

Following the above transactions:

  • The total number of ordinary shares of the Company in issue is 55,379,438
  • The total number of ordinary shares held by Eurocastle in treasury is 18,912,284 (equal to 34.2% of the Company’s share capital)
  • The total number of voting rights exercisable by holders of ordinary shares of the Company is 36,467,154 as voting rights of shares held in treasury are suspended.

ABOUT EUROCASTLE

Eurocastle Investment Limited is a publicly traded closed-ended investment company that focuses on investing in performing and non-performing loans and other real estate related assets primarily in Italy. The Company is Euro denominated and is listed on Euronext Amsterdam under the symbol “ECT”. Eurocastle is managed by an affiliate of Fortress Investment Group LLC, a leading global investment manager. For more information regarding Eurocastle Investment Limited and to be added to our email distribution list, please visit www.eurocastleinv.com.

Set out below are all trades completed 7 October 2019 and 11 October 2019:

  Platform code Volume Price Gross Value (€)
07/10/2019 XLON   575 7.26   4,174.50
  XLON   3 7.30   21.90
  XLON   278 7.30   2,029.40
  BATE   279 7.30   2,036.70
  CHIX   155 7.30   1,131.50
  TRQX    91 7.30   664.30
  XLON   229 7.30   1,671.70
  XLON   771 7.30   5,628.30
    2,381 7.29 17,358.30
08/10/2019 XLON   100 7.30   730.00
  BATE   283 7.30   2,065.90
  CHIX    158 7.30   1,153.40
  TRQX   92 7.30   671.60
  XLON   250 7.30   1,825.00
  XLON   1,000 7.32   7,320.00
  XLON   570 7.32   4,172.40
  XLON   140 7.32   1,024.80
    2,593 7.31 18,963.10
09/10/2019 XLON   229 7.36   1,685.44
  XLON   226 7.36   1,663.36
  XLON   238 7.36   1,751.68
  BATE   123 7.34   902.82
  BATE   160 7.34   1,174.40
  CHIX   158 7.34   1,159.72
  TRQX   88 7.34   645.92
  XLON   519 7.34   3,809.46
  XLON   180 7.34   1,321.20
  XLON   320 7.34   2,348.80
  XLON   186 7.34   1,365.24
  XLON   121 7.34   888.14
    2,548 7.35 18,716.18
10/10/2019 XLON 594 7.32 4,348.08
  XLON 286 7.32 2,093.52
  XLON 285 7.30 2,080.50
  BATE 278 7.32 2,034.96
  CHIX 254 7.32 1,859.28
  XLON 234 7.34 1,717.56
  XLON 229 7.34 1,680.86
  XLON 204 7.32 1,493.28
  XLON 120 7.30 876.00
  TRQX 91 7.32 666.12
  XLON 85 7.30 620.50
  XLON 47 7.30 343.10
    2,707 7.32 19,813.76
11/10/2019 XLON   293 7.28   2,133.04
  XLON   271 7.28   1,972.88
  BATE   236 7.34   1,732.24
  XLON   161 7.30   1,175.30
  CHIX   141 7.34   1,034.94
  TRQX   117 7.34   858.78
  CHIX   116 7.34   851.44
  XLON   19 7.30   138.70
  XLON   1 7.30   7.30
    1,355 7.31 9,904.62
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Correction to Company announcement – No. 23 / 202419.4.2024 22:20:51 CEST | Press release

Correction to Company announcement – No. 23 / 2024 Copenhagen, Denmark, April 19, 2024 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, has a correction to company announcement No. 23 /2024, April 19, 2024 - regarding transactions in Zealand’s shares or related securities conducted by persons discharging managerial responsibilities and/or their closely associated persons it was reported that member of the management, Henriette Wennicke, was allocated a total of 8,008 restricted stock units with a total value of DKK 9,577,568.00. The correct number was a total of 8,008 restricted stock units with a total value of DKK 4,788,784.00. Please see the attached file(s). # # # About Zealand Pharma A/S Zealand Pharma A/S (Nasdaq: ZEAL) ("Zealand") is a biotechnology company focused on the discovery and development of peptide-based medicines. More than 10

Nokia Corporation: Repurchase of own shares on 19.04.202419.4.2024 21:30:00 CEST | Press release

Nokia Corporation Stock Exchange Release 19 April 2024 at 22:30 EEST Nokia Corporation: Repurchase of own shares on 19.04.2024 Espoo, Finland – On 19 April 2024 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows: Trading venue (MIC Code)Number of sharesWeighted average price / share, EUR*XHEL430,8933.30CEUX--BATE--AQEU--TQEX--Total430,8933.30 * Rounded to two decimals On 25 January 2024, Nokia announced that its Board of Directors is initiating a share buyback program to return up to EUR 600 million of cash to shareholders in tranches over a period of two years. The first phase of the share buyback program in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR), the Commission Delegated Regulation (EU) 2016/1052 and under the authorization granted by Nokia’s Annual General Meeting on 4 April 2023 started on 20 March 2024 and ends by 18 December 2024 with a maximum aggregate purchase price of EUR 300 million. Total cost of

Landsbankinn hf.: Results of the 2024 AGM of Landsbankinn19.4.2024 20:48:08 CEST | Press release

The annual general meeting (AGM) of Landsbankinn, held on 19 April 2024, agreed to pay a dividend amounting to ISK 16,535 million to shareholders. The dividend is equivalent to 50% of 2023 profits. The dividend will be paid in two instalments, firstly on 24 April 2024 and secondly on 16 October 2024. As a result, total dividend paid by the Bank in 2013-2024 amounts to ISK 191.7 billion. At the AGM, held in Reykjastræti 6, Helga Björk Eiríksdóttir, Chairman of the Board of Directors, delivered the report from the Board for 2023. Lilja Björk Einarsdóttir, CEO, spoke of the Bank’s operation, strategy and activities in the past operating year. The annual financial statement for the past operating year was approved, as was the proposed Remuneration Policy and remuneration to Directors of the Board. The AGM elected the Auditor General (Ríkisendurskoðun) as auditor of Landsbankinn hf. for the 2024 operating year. The Auditor General, in accordance with an authorisation to outsource tasks, and

SKEL fjárfestingafélag hf.: Styrkás finalizes the purchase of Stólpi Gámar ehf. and affiliated companies.19.4.2024 19:20:57 CEST | Press release

Reference is made to the announcement dated 31 January 2024, regarding Styrkás hf., a company 69.64% owned by SKEL fjárfestingafélag hf., signing a purchase agreement to acquire 100% of the shares in six subsidiaries of Máttarstólpi ehf. The purchase agreement was subject to the approval of the Competition Authority. The transaction was finalized today with payment of purchase price and delivering of shares in the following companies: - Stólpi Gámar ehf., id. 460121-1590, Klettagörðum 5, 104 Reykjavík: - Stólpi Smiðja ehf., id. 460121-1750, Klettagörðum 5, 104 Reykjavík; - Klettskjól ehf., id. 460121-0510, Klettagörðum 5, 104 Reykjavík; - Stólpi ehf., 460121-0430, Klettagörðum 5, 104 Reykjavík; - Tjónaþjónustan ehf., id. 460121-1670, Klettagörðum 5, 104 Reykjavík; - Alkul ehf., id. 491020-0830, Haukdælabraut 48, 113 Reykjavík. collectively referred to as "the sold companies". These companies will continue to be operated on a consolidated basis. The Enterprise value of the sold companie

HiddenA line styled icon from Orion Icon Library.Eye